It has been observed that mutations in this gene (also known as HRPT2) are associated with malignancy in sporadic parathyroid tumors and hereditary hyperparathyroidism-jaw tumor syndrome [49]. This evidence concerns the gene CDC73 and tumor of parathyroid gland.